刚刚，飙涨201%！

Core Viewpoint - The Hong Kong stock market is witnessing a surge in new listings, with several companies, including AI-driven biotech firm Insilico Medicine and GPU-focused Bitmain Technology, set to debut soon, indicating a growing interest in innovative technology sectors [1][4]. Group 1: Insilico Medicine - Insilico Medicine's stock price soared by 201% during the dark trading phase, reaching a peak of 72.30 HKD before closing at 36.86 HKD, reflecting a significant market interest [2]. - The company utilizes its proprietary Pharma.AI platform to accelerate drug discovery, integrating AI and automation to address unmet medical needs in areas such as fibrosis and oncology [2][3]. - Insilico's revenue projections show growth from 30.15 million USD in 2022 to 85.83 million USD in 2024, with adjusted net losses decreasing from 70.80 million USD to 22.67 million USD over the same period [3]. Group 2: Other New Listings - Other companies listing on December 30 include Lin Qingxuan, Meilian Holdings, Xunce Technology, Woan Robotics, and Wuyishijie, with notable price movements observed in the dark trading phase, such as Wuyishijie rising over 50% and Meilian Holdings over 30% [3]. - By the end of the dark trading session, Wuyishijie, Meilian Holdings, and Lin Qingxuan recorded increases of 23.54%, 18.31%, and 18.75% respectively, while Xunce Technology and Woan Robotics experienced declines [3]. Group 3: Bitmain Technology - Bitmain Technology is set to become the first GPU company listed on the Hong Kong Stock Exchange on January 2, 2026, with a significant oversubscription of 1,890 times for its public offering, raising approximately 2.43 billion HKD [5][6]. - The company focuses on developing general-purpose graphics processing units (GPGPU) and intelligent computing solutions, which are essential for AI applications [5][6]. - Bitmain's revenue is projected to grow from 500,000 HKD in 2022 to 337 million HKD in 2024, despite facing substantial adjusted net losses [6].